We are live on ! Find out more
PC

PointState Capital Portfolio holdings

AUM $7.9B
1-Year Est. Return 42.31%
This Fund
S&P 500
This Quarter Est. Return
+8.53%
1 Year Est. Return
+42.31%
3 Year Est. Return
+142.91%
5 Year Est. Return
+261%
10 Year Est. Return
+1,945.58%
AUM
$9.21B
AUM Growth
-$376M
Cap. Flow
-$1.01B
Cap. Flow %
-10.92%
Top 10 Hldgs %
39.08%
Holding
194
New
61
Increased
26
Reduced
38
Closed
60

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$295M
2
MGM icon
MGM Resorts International
MGM
+$236M
3
CCI icon
Crown Castle
CCI
+$185M
4
BABA icon
Alibaba
BABA
+$165M
5
CTRA
Coterra Energy
CTRA
+$161M

Top Sells

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$395M
2
OVV icon
Ovintiv
OVV
+$154M
3
VIAB
Viacom Inc. Class B
VIAB
+$150M
4
FANG icon
Diamondback Energy
FANG
+$120M
5
PNC icon
PNC Financial Services
PNC
+$112M

Sector Composition

Rank Sector Weight
1 Financials 15.88%
2 Communication Services 15.8%
3 Energy 11.19%
4 Consumer Discretionary 10.16%
5 Healthcare 9.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ENDP
126
DELISTED
Endo International plc
ENDP
$726K 0.01%
+65,000
New +$763K
EDN
127
Edenor
EDN
$1.11B
$474K 0.01%
+14,874
New +$491K
RAD
128
DELISTED
Rite Aid Corporation
RAD
$221K ﹤0.01%
+3,750
New +$283K
ONSIW
129
DELISTED
Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019
ONSIW
$17K ﹤0.01%
100,000
– –
ONSIZ
130
DELISTED
Oncobiologics, Inc. Series B Warrant
ONSIZ
$9K ﹤0.01%
100,000
– –
AEE icon
131
Ameren
AEE
$30.5B
– –
-183,500
Closed -$10M
AEP icon
132
American Electric Power
AEP
$70.5B
– –
-145,000
Closed -$9.73M
ALKS icon
133
Alkermes
ALKS
$8.06B
– –
-1,258,000
Closed -$73.6M
BIIB icon
134
CALL
Biogen
BIIB
$30.9B
– –
-10,000
Closed -$2.73M
BIO icon
135
Bio-Rad Laboratories Class A
BIO
$8.75B
– –
-20,100
Closed -$4.01M
BLUE
136
DELISTED
bluebird bio
BLUE
– –
-12,998
Closed -$15.3M
BPMC
137
DELISTED
Blueprint Medicines
BPMC
– –
-129,500
Closed -$5.18M
BSX icon
138
Boston Scientific
BSX
$68.3B
– –
-913,800
Closed -$22.7M
CHRS icon
139
Coherus Oncology
CHRS
$217M
– –
-421,300
Closed -$8.91M
CHTR icon
140
Charter Communications
CHTR
$17.3B
– –
-143,498
Closed -$47M
CI icon
141
Cigna
CI
$78.7B
– –
-12,500
Closed -$1.83M
CMA
142
DELISTED
Comerica
CMA
– –
-30,300
Closed -$2.08M
CNQ icon
143
Canadian Natural Resources
CNQ
$96.9B
– –
-1,503,525
Closed -$24.1M
CRM icon
144
Salesforce
CRM
$154B
– –
-1,192,100
Closed -$104M
EOG icon
145
EOG Resources
EOG
$77.7B
– –
-86,350
Closed -$8.42M
EXC icon
146
Exelon
EXC
$48.1B
– –
-455,930
Closed -$11.7M
FANG icon
147
Diamondback Energy
FANG
$55.9B
– –
-1,155,800
Closed -$120M
FE icon
148
FirstEnergy
FE
$28.4B
– –
-1,700,700
Closed -$54.1M
GD icon
149
General Dynamics
GD
$103B
– –
-224,976
Closed -$42.1M
GLD icon
150
CALL
SPDR Gold Trust
GLD
$131B
– –
-139,400
Closed -$16.6M
4 5
6
7 8

Similar funds

CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
IMRF
Illinois Municipal Retirement Fund Oak Brook, Illinois $7.86B AUM 24.45% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
CMTU
Capital Markets Trading (UK) London, United Kingdom $7.95B AUM 85.98% 1-Year Est. Return
PGFC
Peapack-Gladstone Financial Corp Bedminster, New Jersey $7.82B AUM 21.06% 1-Year Est. Return
EGM
Engineers Gate Manager New York $8B AUM 17.32% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
MT
Midwest Trust Overland Park, Kansas $8.02B AUM 23.54% 1-Year Est. Return

PointState Capital's Q2 2017 Portfolio in Review

As of Q2 2017, PointState Capital held 194 positions worth $9.21B, down 3.9% from $9.59B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

PointState Capital withdrew a net $1.01B in Q2 2017, closing 60 positions and reducing 38 holdings. Its most notable exit was Ovintiv, an estimated $154M position sold in full.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 11% a quarter earlier, followed by Communication Services and Energy.

Against the trend, PointState Capital opened a new position in Citigroup worth $321M.

  • PointState Capital's largest Q2 2017 buy was Citigroup: 4,804,460 shares worth $321M.
  • PointState Capital added most to Alibaba in Q2 2017, an estimated $165M increase.
  • PointState Capital's biggest Q2 2017 reduction was DuPont de Nemours, cutting an estimated $395M.
  • PointState Capital fully exited Ovintiv in Q2 2017, selling an estimated $154M.
  • PointState Capital's ten largest holdings make up 39% of its $9.21B portfolio in Q2 2017.
  • PointState Capital opened 61 new positions and closed 60 in Q2 2017.
  • PointState Capital's portfolio value fell 3.9% quarter-over-quarter to $9.21B.

Based on PointState Capital's 13F filing for Q2 2017, filed 14 Aug 2017.